Search

Home > JAMA Network > JAMA Dermatology : Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Podcast: JAMA Network
Episode:

JAMA Dermatology : Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Category: Science & Medicine
Duration: 00:16:59
Publish Date: 2018-11-21 10:00:00
Description:

Interview with Ivo Abraham, PhD, author of Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
Total Play: 0